1007572-07-7 Usage
Uses
Used in Pharmaceutical Development:
BCPFAA is used as a potential anti-inflammatory agent for the development of new pharmaceuticals. Its unique structure, which includes bromine, fluorine, chlorine, and cyanophenoxy substituents, contributes to its biological activity and may help in the treatment of inflammatory conditions.
Used in Research and Development:
BCPFAA is used as a research compound to further understand its properties and potential applications. [4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl]acetic acid's structure and biological activity make it an interesting subject for scientific investigation, which may lead to the discovery of new therapeutic approaches for various inflammatory diseases.
Used in Drug Design and Synthesis:
BCPFAA serves as a starting point for drug design and synthesis, as its unique structure and potential anti-inflammatory properties can be further optimized and modified to develop more effective and targeted pharmaceuticals for the treatment of specific inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1007572-07-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,5,7 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1007572-07:
(9*1)+(8*0)+(7*0)+(6*7)+(5*5)+(4*7)+(3*2)+(2*0)+(1*7)=117
117 % 10 = 7
So 1007572-07-7 is a valid CAS Registry Number.
1007572-07-7Relevant academic research and scientific papers
Sweeney, Zachary K.,Harris, Seth F.,Arora, Nidhi,Javanbakht, Hassan,Li, Yu,Fretland, Jennifer,Davidson, James P.,Billedeau, J. Roland,Gleason, Shelley K.,Hirschfeld, Donald,Kennedy-Smith, Joshua J.,Mirzadegan, Taraneh,Roetz, Ralf,Smith, Mark,Sperry, Sarah,Suh, Judy M.,Wu, Jeffrey,Tsing, Stan,Villase?or, Armando G.,Paul, Amber,Su, Guoping,Heilek, Gabrielle,Hang, Julie Q.,Zhou, Amy S.,Jernelius, Jesper A.,Zang, Fang-Jie,Klumpp, Klaus
, p. 7449 - 7458 (2008)
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are recommended components of preferred combination antiretroviral therapies used for the treatment of HIV. These regimens are extremely effective in suppressing virus replication. Structure-based o
